APA

Ulloa C. E., Anglicheau D., Snanoudj R., Scemla A., Martinez F., Timsit M., Legendre C. & Sberro-Soussan R. (20200619). Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies. : Transplantation.

Chicago

Ulloa Camilo E, Anglicheau Dany, Snanoudj Renaud, Scemla Anne, Martinez Frank, Timsit Marc-Olivier, Legendre Christophe and Sberro-Soussan Rebecca. 20200619. Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies. : Transplantation.

Harvard

Ulloa C. E., Anglicheau D., Snanoudj R., Scemla A., Martinez F., Timsit M., Legendre C. and Sberro-Soussan R. (20200619). Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies. : Transplantation.

MLA

Ulloa Camilo E, Anglicheau Dany, Snanoudj Renaud, Scemla Anne, Martinez Frank, Timsit Marc-Olivier, Legendre Christophe and Sberro-Soussan Rebecca. Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies. : Transplantation. 20200619.